Previous 10 | Next 10 |
Co-Diagnostics, Inc. to Present and Host Booth at TRI-CON in San Diego, CA, March 6-8 PR Newswire SALT LAKE CITY , March 2, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, pat...
Co-Diagnostics, Inc. to Host Booth at 89th Annual AMCA Conference in Reno, NV on Feb 28-March 3 PR Newswire SALT LAKE CITY , Feb. 28, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, pate...
Co-Diagnostics, Inc. Initiates Clinical Evaluations for its At-Home and Point-of-Care Co-Dx PCR Home™ Platform PR Newswire SALT LAKE CITY , Feb. 22, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular ...
Summary CODX is a manufacturer of PCR tests. The company also holds two patents on specific PCR methods that increase the test's accuracy. Before the pandemic, the company had little revenue and enormous losses. Today, the company's losses are higher, albeit selling much more and holdin...
Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2023 in Dubai on February 6-9 PR Newswire SALT LAKE CITY , Feb. 2, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented ...
Co-Diagnostics, Inc. Commemorates Third Anniversary of the Completion of its First COVID-19 Test Design PR Newswire Designed using the Company's proprietary platform, initial test design remains effective detection tool even after three years of variants and more than 33 mil...
Co-Diagnostics, Inc. to Host Booth at CES 2023 January 5-8 PR Newswire SALT LAKE CITY , Jan. 5, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the de...
Co-Diagnostics, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022 PR Newswire SALT LAKE CITY , Nov. 30, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnosti...
Co-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany PR Newswire SALT LAKE CITY , Nov. 14, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with...
Co-Diagnostics, Inc. (CODX) Q3 2022 Earnings Conference Call November 10, 2022, 04:30 PM ET Company Participants Dan Bohrer - VP, Finance and Accounting Dwight Egan - CEO Brian Brown - CFO Conference Call Participants Theodore O'Neill - Litchfield Hil...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address PR Newswire Presentation included announcement of the opening of the new manufacturing facility in Salt Lake City, UT SALT LAKE CITY , March 21, 202...
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England PR Newswire SALT LAKE CITY, Utah , March 18, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company...
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results PR Newswire SALT LAKE CITY , March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagno...